← Browse entries

Gmfb

M. musculus

glia maturation factor beta

What the model saw

Gene: GMFB
Organism: Mus musculus
Known functions: glia maturation factor beta. Arp2/3 complex binding. actin binding. enzyme activator activity. protein kinase inhibitor activity.
View unredacted entry
glia maturation factor beta. Arp2/3 complex binding. actin binding. enzyme activator activity. protein kinase inhibitor activity.

Solver output

Predicted influence
Unclear
Confidence
38%
Mechanism
Other
Reasoning

GMFB (Glia Maturation Factor Beta) binds and activates the Arp2/3 complex to regulate actin cytoskeleton dynamics, but paradoxically also acts as a debranching factor that inhibits Arp2/3-mediated actin nucleation. Its protein kinase inhibitor activity has been linked to inhibition of MAP kinases (e.g., ERK/JNK), which are involved in stress responses and inflammatory signaling. While actin cytoskeletal regulation and MAP kinase modulation both intersect with aging-relevant processes (cellular senescence, neuroinflammation), the dual and opposing roles of GMFB in actin dynamics (activator vs. debrancher of Arp2/3) and its kinase inhibitory effects on pathways with context-dependent pro- or anti-aging outcomes make a clear directional prediction difficult. No strong, consistent evidence links GMFB's specific molecular functions to a net pro- or anti-longevity outcome in mice.

Key pathways
Arp2/3-mediated actin cytoskeleton remodelingMAP kinase signaling inhibitionneuroinflammation and glia maturation
Longevity influence
Anti-longevity
Lifespan effect
Decrease

GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.

Advisor judgment

Answer
Incorrect
Mechanism
Incorrect
Reasoning quality
2/5
Failure mode
Appropriately uncertain
Notes

The model predicted "unclear" while the ground truth is "anti_longevity." The model's reasoning about GMFB's dual roles in actin dynamics and MAP kinase inhibition is plausible but doesn't arrive at the correct directional conclusion. The model was appropriately uncertain given limited direct evidence, but ultimately failed to identify the anti-longevity classification. The reasoning quality is moderate - it correctly identifies relevant pathways but fails to synthesize them into a directional prediction. The confidence of 0.38 reflects genuine uncertainty, which is somewhat appropriate given the obscurity of this gene in aging research, but the answer is still wrong.

Raw API responses

solver

{
  "reasoning": "GMFB (Glia Maturation Factor Beta) binds and activates the Arp2/3 complex to regulate actin cytoskeleton dynamics, but paradoxically also acts as a debranching factor that inhibits Arp2/3-mediated actin nucleation. Its protein kinase inhibitor activity has been linked to inhibition of MAP kinases (e.g., ERK/JNK), which are involved in stress responses and inflammatory signaling. While actin cytoskeletal regulation and MAP kinase modulation both intersect with aging-relevant processes (cellular senescence, neuroinflammation), the dual and opposing roles of GMFB in actin dynamics (activator vs. debrancher of Arp2/3) and its kinase inhibitory effects on pathways with context-dependent pro- or anti-aging outcomes make a clear directional prediction difficult. No strong, consistent evidence links GMFB's specific molecular functions to a net pro- or anti-longevity outcome in mice.",
  "confidence": 0.38,
  "key_pathways": [
    "Arp2/3-mediated actin cytoskeleton remodeling",
    "MAP kinase signaling inhibition",
    "neuroinflammation and glia maturation"
  ],
  "mechanism_class": "other",
  "longevity_influence": "unclear"
}

advisor

{
  "notes": "The model predicted \"unclear\" while the ground truth is \"anti_longevity.\" The model's reasoning about GMFB's dual roles in actin dynamics and MAP kinase inhibition is plausible but doesn't arrive at the correct directional conclusion. The model was appropriately uncertain given limited direct evidence, but ultimately failed to identify the anti-longevity classification. The reasoning quality is moderate - it correctly identifies relevant pathways but fails to synthesize them into a directional prediction. The confidence of 0.38 reflects genuine uncertainty, which is somewhat appropriate given the obscurity of this gene in aging research, but the answer is still wrong.",
  "failure_mode": "appropriately_uncertain",
  "answer_correct": false,
  "mechanism_correct": false,
  "reasoning_quality": 2,
  "ground_truth_questionable": false
}